Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | NPC1 | O15118 | 2/20 | 0.56 |
| ▸ | RAB9A | P51151 | 2/20 | 0.56 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.56 |
| ▸ | XBP1 | P17861 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.43 |
| ▸ | MRGPRX1 | Q96LB2 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27423640 | 0.88 | SMN1; SMN2 (0.62) | SMN1; SMN2MAPTALDH1A1LMNANPC1 | |
| SCHEMBL15490439 | 0.81 | SMN1; SMN2 (0.41) | SMN1; SMN2MAPTALDH1A1LMNANPC1 | |
| SCHEMBL307909 | 0.81 | MEN1 (0.49) | SMN1; SMN2MAPTALDH1A1LMNANPC1 | |
| SCHEMBL12825961 | 0.81 | SMN1; SMN2 (0.55) | SMN1; SMN2MAPTALDH1A1LMNANPC1 | |
| SCHEMBL26697193 | 0.80 | ALDH1A1 (0.39) | SMN1; SMN2MAPTALDH1A1LMNANPC1 | |
| SCHEMBL21610167 | 0.80 | SMN1; SMN2 (0.53) | SMN1; SMN2MAPTALDH1A1LMNANPC1 | |
| SCHEMBL10074114 | 0.80 | CYP1A2 (0.43) | SMN1; SMN2MAPTALDH1A1LMNANPC1 | |
| SCHEMBL22567997 | 0.80 | GAA (0.43) | SMN1; SMN2MAPTALDH1A1LMNANPC1 | |
| SCHEMBL5319903 | 0.80 | RAF1 (0.42) | SMN1; SMN2MAPTALDH1A1LMNANPC1 | |
| SCHEMBL22558105 | 0.78 | ALDH1A1 (0.38) | SMN1; SMN2MAPTALDH1A1LMNANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12024492-B2 | Process for preparation of azoxystrobin and intermediates thereof | UPL LTD (IN) | 2024-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12024492-B2 | Process for preparation of azoxystrobin and intermediates thereof | NISCH, STS, SNX2 | SMN1; SMN2 3076/4885MAPT 4720/4885ALDH1A1 1069/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.